{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:52:26Z","timestamp":1781520746905,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.jvca.2026.03.019","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:16:01Z","timestamp":1773458161000},"page":"1926-1928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten Years After the Tsunami: The SCA\/STS Guidelines for the Management of Direct Oral Anticoagulants in Cardiac Surgery: Focus on Anti-Xa Agents"],"prefix":"10.1053","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-1016","authenticated-orcid":false,"given":"Gabor","family":"Erdoes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.03.019_bib0001","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: A short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans","year":"2022","journal-title":"Cells"},{"key":"10.1053\/j.jvca.2026.03.019_bib0002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/hematology.2024000666","article-title":"DOACs: Role of anti-Xa and drug level monitoring","volume":"1","author":"Mithoowani","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1053\/j.jvca.2026.03.019_bib0003","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000007868","article-title":"Management of direct oral anticoagulants in adult patients undergoing cardiac surgery: A joint consensus statement by the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons","author":"Budd","year":"2026","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2026.03.019_bib0004","doi-asserted-by":"crossref","first-page":"ezae355","DOI":"10.1093\/ejcts\/ezae355","article-title":"EACTS Scientific Document Group. 2024 EACTS guidelines on perioperative medication in adult cardiac surgery","volume":"67","author":"Jeppsson","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2026.03.019_bib0005","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1053\/j.jvca.2024.10.006","article-title":"EACTS\/EACTAIC\/EBCP Scientific Document Group. 2024 EACTS\/EACTAIC guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP","volume":"39","author":"Casselman","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.019_bib0006","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/EJA.0000000000001968","article-title":"Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding","volume":"41","author":"Grottke","year":"2024","journal-title":"Eur J Anaesthesiol"},{"key":"10.1053\/j.jvca.2026.03.019_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102899","article-title":"Investigating interassay variability between direct oral anticoagulant calibrated anti-factor Xa assays: A substudy of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) trial","volume":"9","author":"Baker","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.019_bib0008","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jth.13227","article-title":"Subcommittee on Control of Anticoagulation. When and how to use antidotes for the reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH","volume":"14","author":"Levy","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.019_bib0009","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jtha.2025.02.026","article-title":"How to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"23","author":"Gendron","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.019_bib0010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bjh.17470","article-title":"A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: Method validation, diagnostic accuracy and external validation","volume":"193","author":"Willekens","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2026.03.019_bib0011","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"ANNEXA-I Investigators. Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.03.019_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.817826","article-title":"Accuracy of a single, heparin-calibrated anti-Xa assay for the measurement of rivaroxaban, apixaban, and edoxaban drug concentrations: A prospective cross-sectional study","volume":"9","author":"Meihandoest","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1053\/j.jvca.2026.03.019_bib0013","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.jvca.2022.01.038","article-title":"In vitro apixaban removal by CytoSorb whole blood adsorber: An experimental study","volume":"36","author":"R\u00f8ed-Undlien","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.019_bib0014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ehjcvp\/pvac036","article-title":"Antithrombotic drug removal from whole blood using haemoadsorption with a porous polymer bead sorbent","volume":"8","author":"Tripathi","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1053\/j.jvca.2026.03.019_bib0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11239-024-02996-x","article-title":"Intraoperative haemoadsorption for antithrombotic drug removal during cardiac surgery: Initial report of the International Safe and Timely Antithrombotic Removal (STAR) registry","volume":"57","author":"Schmoeckel","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2026.03.019_bib0016","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13019-024-03326-1","article-title":"Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and\/or single valve surgery: Interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry","volume":"20","author":"Schmoeckel","year":"2025","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2026.03.019_bib0017","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1053\/j.jvca.2025.02.043","article-title":"The next wave: Are we prepared for patients on anticoagulation with factor XI inhibitors in cardiac surgery?","volume":"39","author":"Erdoes","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026002193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026002193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:53:42Z","timestamp":1781517222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026002193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1053077026002193"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.03.019","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten Years After the Tsunami: The SCA\/STS Guidelines for the Management of Direct Oral Anticoagulants in Cardiac Surgery: Focus on Anti-Xa Agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}